Haemonetics Corporation (HAE)

Healthcare · Medical Devices · NYSE

Haemonetics Corporation (HAE) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $4.00B, a trailing price-to-earnings ratio of 17.5 and a free-cash-flow yield of 6.3%. Over the most recent reported fiscal year, revenue declined 2.0% and free cash flow per share grew 95.9%.

Market cap	$4.00B
Trailing P/E	17.5
FCF yield	6.3%
Revenue growth (YoY)	-2.0%
EPS growth (YoY)	+8.8%
FCF/share growth (YoY)	+95.9%
Exchange	NYSE
Sector	Healthcare
Industry	Medical Devices

Explore live HAE data on Nama Insights →

Recent Congressional trades

Haemonetics Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lois Frankel	House	Sell	$1,001 - $15,000	May 7, 2021
Josh Gottheimer	House	Sell	$1,001 - $15,000	Feb 5, 2021
Josh Gottheimer	House	Buy	$1,001 - $15,000	Nov 4, 2020
Lois Frankel	House	Buy	$1,001 - $15,000	Aug 14, 2020
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 11, 2020
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 11, 2020
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jun 8, 2020
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jun 8, 2020